Combined immunomodulatory therapies resulted in stepwise recovery in autoimmune autonomic ganglionopathy

Clinical and Experimental Neuroimmunology

Volumn 6, Issue 2, 2015, Pages 191-194

  Nishihara, Hideaki ^a   Koga, Michiaki ^a   Higuchi, Osamu ^b   Tasaki, Ayako ^a   Ogasawara, Jun Ichi ^a   Kawai, Motoharu ^a   Nakane, Shunya ^b   Kanda, Takashi ^a  

^a YAMAGUCHI UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Nagasaki Kawatana Medical Center   (Japan)

Author keywords

autoimmune autonomic ganglionopathy; combined immunomodulatory therapy; intravenous immunoglobulin; plasma exchange; steroid

Indexed keywords

CHOLINERGIC RECEPTOR ANTIBODY; IMMUNOGLOBULIN G; METHYLPREDNISOLONE; PREDNISONE;

ADULT; ARTICLE; AUTOIMMUNE AUTONOMIC GANGLIONOPATHY; AUTOIMMUNE DISEASE; AUTONOMIC DYSFUNCTION; BLADDER CATHETERIZATION; CASE REPORT; CONSTIPATION; DRY EYE; DYSURIA; HUMAN; HYPOTONIC BLADDER; IMMUNOPRECIPITATION; IMMUNOTHERAPY; LUCIFERASE ASSAY; MALE; MIDDLE AGED; MULTIPLE CYCLE TREATMENT; ORTHOSTATIC HYPOTENSION; PRESYNCOPE; PRIORITY JOURNAL; RADIOIMMUNOASSAY; SELF CONCEPT; STEROID THERAPY; XEROSTOMIA;

EID: 84928954295     PISSN: None     EISSN: 17591961     Source Type: Journal    
DOI: 10.1111/cen3.12137     Document Type: Article

References (17)

1. Vernino S, Adamski J, Kryzer TJ, et al. Neuronal nicotinic ACh receptor antibody in subacute autonomic neuropathy and cancer-related syndromes. Neurology. 1998; 50 (6): 1806-13.
2. Vernino S, Low PA, Fealey RD, et al. Autoantibodies to ganglionic acetylcholine receptors in autoimmune autonomic neuropathies. N Engl J Med. 2000; 343 (12): 847-55.
3. Koike H, Hashimoto R, Tomita M, et al. The spectrum of clinicopathological features in pure autonomic neuropathy. J Neurol. 2012; 259 (10): 2067-75.
4. Iodice V, Kimpinski K, Vernino S, et al. Efficacy of immunotherapy in seropositive and seronegative putative autoimmune autonomic ganglionopathy. Neurology. 2009; 72 (23): 2002-8.
5. Heafield MT, Gammage MD, Nightingale S, et al. Idiopathic dysautonomia treated with intravenous gammaglobulin. Lancet. 1996; 347 (8993): 28-9.
6. Schroeder C, Vernino S, Birkenfeld AL, et al. Plasma exchange for primary autoimmune autonomic failure. N Eng J Med. 2005; 353 (15): 1585-90.
7. Gibbons CH, Vernino SA, Freeman R,. Combined immunomodulatory therapy in autoimmune autonomic ganglionopathy. Arch Neurol. 2008; 65 (2): 213-7.
8. Modoni A, Mirabella M, Madia F, et al. Chronic autoimmune autonomic neuropathy responsive to immunosuppressive therapy. Neurology. 2007; 68 (2): 161-2.
9. Imrich R, Vernino S, Eldadah BA, et al. Autoimmune autonomic ganglionopathy: treatment by plasma exchanges and rituximab. Clin Auton Res. 2009; 19 (4): 259-62.
10. Dale RC, Lang B, Brilot F, et al. Treatment-responsive pandysautonomia in an adolescent with ganglionic α3-AChR antibodies. Eur J Paediatr Neurol. 2012; 16 (4): 396-8.
11. Burbelo PD, Ching KH, Klimavicz CM, et al. Antibody profiling by luciferase immunoprecipitation systems (LIPS). J Vis Exp. 2009; 7 (32): e1549.
12. Higuchi O, Hamuro J, Motomura M, et al. Autoantibodies to low-density lipoprotein receptor-related protein 4 in myasthenia gravis. Ann Neurol. 2011; 69 (2): 418-22.
13. Kim SB, Suzuki H, Sato M, et al. Superluminescent variants of marine luciferases for bioassays. Anal Chem. 2011; 83 (22): 8732-40.
14. Klein CM, Vernino S, Lennon VA, et al. The spectrum of autoimmune autonomic neuropathies. Ann Neurol. 2003; 53 (6): 752-8.
15. Kimpinski K, Iodice V, Sandroni P, et al. Sudomotor dysfunction in autoimmune autonomic ganglionopathy. Neurology. 2009; 73 (18): 1501-6.
16. Manganelli F, Dubbioso R, Nolano M, et al. Autoimmune autonomic ganglionopathy: a possible postganglionic neuropathy. Arch Neurol. 2011; 68 (4): 504-7.
17. Vernino S, Ermilov LG, Sha L, et al. Passive transfer of autoimmune autonomic neuropathy to mice. J Neurosci. 2004; 24 (32): 7037-42.